NCT03164499 is a NA clinical trial of Individual counselling on lifestyles in Cardiovascular Risk Factor, sponsored by Fundacion para la Investigacion y Formacion en Ciencias de la Salud.

Who is sponsoring NCT03164499?

NCT03164499 is sponsored by Fundacion para la Investigacion y Formacion en Ciencias de la Salud.

What drugs are being tested in NCT03164499?

Interventions in NCT03164499: Individual counselling on lifestyles, Additional group counselling on lifestyles.

What condition does NCT03164499 study?

NCT03164499 studies Cardiovascular Risk Factor.

Is NCT03164499 still recruiting?

NCT03164499 is currently completed. Last updated 16 April 2019.

Last reviewed 2019-04-16 · How we verify

NCT03164499

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intensive Intervention to Improve Lifestyles in Subjects With Intermediate Cardiovascular Risk.

Completed NA Last updated 16 April 2019

What this trial tests

NA trial testing Individual counselling on lifestyles in Cardiovascular Risk Factor in 203 participants. Completed in 31 March 2019.

Timeline

1 June 2017

Primary endpoint
31 December 2018

31 March 2019

Quick facts

Lead sponsor	Fundacion para la Investigacion y Formacion en Ciencias de la Salud
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	203
Start date	1 June 2017
Primary completion	31 December 2018
Estimated completion	31 March 2019
Sites	1 location across Spain

Drugs / interventions tested

Individual counselling on lifestyles
Additional group counselling on lifestyles

Conditions studied

Cardiovascular Risk Factor — all drugs for Cardiovascular Risk Factor →

Sponsor

Fundacion para la Investigacion y Formacion en Ciencias de la Salud

Who can join

Adults 35 to 74, any sex, with Cardiovascular Risk Factor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized controlled trial aimed to design an intensive intervention to modify lifestyles of subjects with intermediate cardiovascular risk and evaluate its effectiveness. 200 participants aged 35-74 years who have intermediate cardiovascular risk will be included. Subjects will be selected by consecutive sampling at urban primary care health centers from Salamanca (Spain) and they will be randomized to a control or an intervention group. Both groups will receive individual standardized counselling on healthy diet, daily physical activity, smoking cessation, and moderation in alcohol consumption. Moreover, individuals from the intervention group will receive additional group counselling and follow-up calls. The effect of the intervention will be assessed using lifestyles and quality of life questionnaires, metabolic control parameters, inflammation markers, anthropometric and vascular function measurements, and neuropsychological tests.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Strategies to improve smoking cessation rates in primary care.
Lindson N, Pritchard G, Hong B, Fanshawe TR, et al · · 2021 · cited 45× · PMID 34693994 · DOI 10.1002/14651858.cd011556.pub2

Verify or expand the search:

Other recruiting trials for Cardiovascular Risk Factor

Currently open trials in the same condition.

NCT07268781 — Impact of Golden Rice-Piper Crocatum Cookies on Lipid Control in Diabetes Mellitus Patients · NA · active not recruiting
NCT06225544 — Lumasiran in Hyperoxalaemic Patients on Haemodialysis · Phase 2 · recruiting
NCT06372054 — TORNADO-Omics Techniques and Neural Networks for the Development of Predictive Risk Models · recruiting
NCT05887622 — The Potassium Supplementation Study · NA · recruiting
NCT04962061 — A Combined Multidomain Intervention to Prevent Cognitive Decline Associated With Cardiovascular Risk Factors. · NA · recruiting

Other Fundacion para la Investigacion y Formacion en Ciencias de la Salud trials

Trials by the same sponsor.

NCT05866133 — Relationship of Addictions to Obesity, Physical Activity and Vascular Ageing in Young Adults · unknown
NCT05819840 — Vascular Structure, Vascular Function and Vascular Aging in Adults Diagnosed With Persistent COVID · unknown
NCT05912088 — Elderly Falls Prevention With sLiFE Program in Primary Care · NA · unknown
NCT05986110 — Analysis of the Results Obtained in the Regular Clinical Practice of a Clinical Ultrasound Classroom For Primary Care Ph · NA · unknown
NCT05625295 — Tele-dermatology Non-presential (TeleDermaSA) · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03164499 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fundacion para la Investigacion y Formacion en Ciencias de la Salud
Last refreshed: 16 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03164499.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing